🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2023-01-10
Trial ID
NCT04673175
Treatments Being Tested
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
The purpose of this study is to compare the Instillation Technique Using Th...
Status
Unknown
Location
Southeastern Regional Medical Center
Start Date
2014-06
Trial ID
NCT02368067
Treatments Being Tested
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The purpose of this study is to assess if a zoledronic acid injection can a...
Status
Terminated
Location
University of Calgary
Start Date
2023-05-16
Trial ID
NCT05204836
Treatments Being Tested
This is a randomized, double blinded, standard of care controlled clinical ...
Status
Completed
Location
Henry Ford Hospital
Start Date
2016-04
Trial ID
NCT02740192
Treatments Being Tested
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe...
Status
Completed
Location
Lucile Packard Childrens Hospital
Start Date
2024-01-29
Trial ID
NCT05208892
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested